DIN 02229021 — ISOVUE 300 INJECTION 61 %
ISOVUE 300 INJECTION is a liquid of Iopamidol marketed by BRACCO IMAGING CANADA. The full Iopamidol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02229021
- Brand name
- ISOVUE 300 INJECTION
- Active ingredient
- Iopamidol
- Strength
- 61 %
- Dosage form
- LIQUID
- Route
- INTRAVASCULAR
- Manufacturer
- BRACCO IMAGING CANADA
- Health Canada status
- MARKETED
- Drug class
- Non-ionic, low-osmolar iodinated radiographic contrast agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Iopamidol products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02229013 | ISOVUE 200 INJECTION | 41 % | SOLUTION | BRACCO IMAGING CANADA | MARKETED |
| 02229048 | ISOVUE 370 INJECTION | 76 % | LIQUID | BRACCO IMAGING CANADA | MARKETED |
| 02242122 | ISOVUE MULTIPACK-300 | 61 % | LIQUID | BRACCO IMAGING CANADA | MARKETED |
| 02242121 | ISOVUE MULTIPACK-370 | 76 % | LIQUID | BRACCO IMAGING CANADA | MARKETED |